Sampra Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 19-12-2024
- Paid Up Capital ₹ 1.00 M
as on 19-12-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 0.80 M
as on 19-12-2024
- Revenue -57.47%
(FY 2019)
- Profit -647.12%
(FY 2019)
- Ebitda 330.99%
(FY 2019)
- Net Worth -3.28%
(FY 2019)
- Total Assets 77.79%
(FY 2019)
About Sampra Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹0.80 M.
Shailesh Gupta and Sunil Singh serve as directors at the Company.
- CIN/LLPIN
U24100UP2014PTC062039
- Company No.
062039
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2014
- Date of AGM
21 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sampra Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Gupta  | Director | 16-Jul-2022 | Current |
| Sunil Singh | Director | 18-Jan-2024 | Current |
Financial Performance of Sampra Pharma.
Sampra Pharma Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 57.47% decrease. The company also saw a substantial fall in profitability, with a 647.12% decrease in profit. The company's net worth dipped by a decrease of 3.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sampra Pharma?
In 2019, Sampra Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lumina Solar Private LimitedActive 5 years 10 monthsShailesh Gupta and Sunil Singh are mutual person
- Vaibhavi And Vinayak Marketing Private LimitedActive 2 years 6 months
Sunil Singh is a mutual person
- Gramin Khaad Evam Beej Sahkaari Kendra AssociationActive 3 years 2 months
Sunil Singh is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
United Bank Of India Creation Date: 17 Aug 2018 | ₹0.80 M | Open |
How Many Employees Work at Sampra Pharma?
Unlock and access historical data on people associated with Sampra Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sampra Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sampra Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
